Posts Tagged ‘Healthcare’
Limula wins a prestigious EIC grant of €4.7 million
By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.
Read MoreCHUV strengthens its strategy to fight cancer
The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The institution is opening three new interdisciplinary oncology centers, focusing on the brain and spinal cord, liver and pancreas, and ENT and cervicofacial tumors. The University Hospital of Vau, CHUV, had already been a pioneer…
Read MoreBioAlps at OM Pharma
On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma in Geneva. OM Pharma is a leader in the prevention of recurrent respiratory and urinary tract infections with products regulating the immune system based on oral bacterial extracts. Broncho-Vaxom® and Uro Vaxom® are marketed…
Read MoreCytiva opens a new production site in Grens (VD)
Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022. The site will manufacture single-use kits for the Sepax and Sefia cell processing systems, as well as consumables for the Xuri cell expansion systems. The new site will be home to 250 employees and house the Centre of Excellence…
Read MoreVotes are open for the TOP 100 Swiss Startups!
What is your favorite swiss startup? Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups. 438 Swiss deeptech startups have been featured in the ranking over the past decade. So far, they have created 11100 jobs and raised CHF 6.1 billion. In 2022, 269 Life Sciences…
Read MorePr. Antoine Geissbuhler is the new BioAlps’ President
A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster in Europe After a selection process of several months, BioAlps’ Executive Committee identified a strong candidate to take over the role of Mr Claude Clément as President of the BioAlps Association. On Thursday 19…
Read MoreAlithea Genomics closes a CHF 1 million seed round
Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with the participation of Swiss-based private investors. Alithea has developed a proprietary technology called Bulk RNA Barcoding and sequencing (BRB-seq), which enables the preparation…
Read MoreDr. Andrea Pfeifer received the Aenne Burda Award
The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease AC Immune SA (NASDAQ: ACIU), a Lausanne-based clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, announced that Dr. Andrea Pfeifer, CEO and a Director of AC Immune, was awarded the prestigious Aenne Burda Award…
Read MoreKodiak Sciences and Lonza open a new facility in Visp
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases, and Lonza announced on 17 May 2022 the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp, Switzerland. The facility will play a key role in the scaled…
Read MoreSwiss biotech companies attracted investments of $3.33 billion in 2021
Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited from a “still strong” international contribution. Of the $3.33 billion, $2.51 billion was invested in listed companies, including Sophia Genetics in Lausanne, with $234 million following its initial public offering (IPO) and its follow-up,…
Read More